Pilar Domingo-Calap
PI Environmental and Biomedical Virology Lab #EnBiVirLab
Universitat de Valencia-CSIC
@VLCphagehunters
Co-founder and CSO at Evolving Therapeutics
@evolving_spain
Spain
- Reposted by Pilar Domingo-Calap🗞️Un estudi liderat per @pilardomingoc.bsky.social , professora de la Facultat, i @celiaferriolg.bsky.social , doctoranda en Biodiversitat i Biologia Evolutiva, revela com certs virus evolucionen i s’adapten per a infectar nous bacteris. 🔗Més informació:
- Reposted by Pilar Domingo-CalapMy @i2sysbio.es colleagues Lucas Mora, Rafael Sanjuan @rafa-sanjuan.bsky.social and Pilar Domingo Calap @pilardomingoc.bsky.social published a paper about reversible phenotypic resistance to phages in Klebsiella. 👏👏 Congratulations! 🧬🖥🧪🦠🧫 #microsky #viruses #phages www.cell.com/iscience/ful...
- Reposted by Pilar Domingo-CalapMy @i2sysbio.es colleague Pilar Domingo-Calap @pilardomingoc.bsky.social speaking at the Pangenome congress in Valencia 🇪🇸 about the success of the personalized #phage therapy achieved by her company Evolving Therapeutics and phage experimental evolution done in her lab 👏👏👏 #microsky #viruses 🧬🖥🧪🦠🧫
- Reposted by Pilar Domingo-CalapCapsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
- Reposted by Pilar Domingo-CalapCapsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
- Very proud of @celiaferriolg.bsky.social! Amazing experimental evolution for phage optimization and for host range expansion, allowing us to understand the evolvability of phage RBPs. This work is part of her PhD project at the #EnBivirLab @i2sysbio.es @uv.es @ccbiologiquesuv.bsky.social
- Capsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
- Reposted by Pilar Domingo-CalapCapsule diversity limits #phage host range by affecting receptor-binding protein (RBP) interactions in capsulated #bacteria. @pilardomingoc.bsky.social &co show that generalist phages evolve host range via RBP mutation & recombination, but specialists remain stable @plosbiology.org 🧪 plos.io/48nvOqY
- Reposted by Pilar Domingo-CalapThe host range of generalist and specialist phages in capsule-diverse Klebsiella hosts is driven by the evolvability of receptor-binding proteins @plosbiology.org from @pilardomingoc.bsky.social journals.plos.org/plosbiology/...
- Reposted by Pilar Domingo-Calap👉 EVOLVING THERAPEUTICS, s'encarrega de la prevenció, diagnòstic i tractament de bacteris patògens resistents a antibiòtics amb una metodologia basada en fags. Cofundada i dirigida per @pilardomingoc.bsky.social , exalumna i professora de la Facultat. ▶️ go.uv.es/Is1CpTJ
- Reposted by Pilar Domingo-CalapPer finalitzar l' Inoovation Stage de #VDS, tots els participants pujen per fer una #taularodona.
- Reposted by Pilar Domingo-Calap🌀Envolving Therapeutics, spin-off de @ccbiologiquesuv.bsky.social al #VDS com a empresa del Parc Científic.
- Reposted by Pilar Domingo-Calap👩🏼🔬 @pilardomingoc.bsky.social , exalumna de @ccbiologiquesuv.bsky.social i actual professora, dóna a conèixer la seu empresa, Envolving Therapeutics, al Innovation Stage de #VDS.
- Reposted by Pilar Domingo-Calap🎉👏 #I2SysBio (@uv.es - @csic.es) researchers Rafael Sanjuán, Andrés Moya and @pilardomingoc.bsky.social are included in Stanford University's Word Ranking Scientists. This ranking recognises the top 2% of authors worldwide for the excellence of their intellectual output. www.uv.es/uvweb/biolog...
- Proud to be included in the top 2% World Ranking of Scientist @stanforduniversity.bsky.social, and to be the only woman at my Faculty in 2024 @ccbiologiquesuv.bsky.social. Thanks to my lab #EnBiVirLab @i2sysbio.es @uv.es @csic.es, all collaborators, and special thanks to all #VLCPhageHunters!
- 🗞️Investigadors de la @ccbiologiquesuv.bsky.social al Stanford University - World Ranking of Scientists dels més influents del món. 🖇️Més informació: links.uv.es/6egolOY
- Reposted by Pilar Domingo-Calap📰Investigadors de l'I² SysBio desenrotllen una IA pionera per a predir l'acció dels fags contra bacteris. 🖇️Més informació: links.uv.es/4plKymq
- Reposted by Pilar Domingo-Calap#UVCiència @beatrizbeamud.bsky.social @pilardomingoc.bsky.social @rafa-sanjuan.bsky.social @i2sysbio.es @uv.es www.uv.es/uvweb/unitat...
- Reposted by Pilar Domingo-Calap👩🔬La investigadora del #I2SysBio (@uv.es-@csic.es) @pilardomingoc.bsky.social ha sido propuesta por la revista Magas de @elespanol.com para formar parte del Top 100 Mujeres Líderes. 🔗Te invitamos a leer su propuesta y votarla. 💜¡Enhorabuena, Pilar! www.elespanol.com/mujer/lastop...
- Reposted by Pilar Domingo-CalapUna paciente con fibrosis quística e infección crónica causada por P. aeruginosa supera un rechazo agudo de trasplante pulmonar gracias a una terapia basada en la combinación de fagos, inmunosupresores y antibióticos. Estudio liderado por @pilardomingoc.bsky.social elpais.com/ciencia/2025...
- Reposted by Pilar Domingo-CalapA patient with cystic fibrosis overcomes rejection of lung transplant through phage therapy! My colleagues from @i2sysbio.es led by Pilar Domingo Calap @pilardomingoc.bsky.social are saving patients' lives with phages. Truly admirable! 👏 www.i2sysbio.es/communicatio... #microsky #phages #viruses 🧪🦠🧫
- Reposted by Pilar Domingo-CalapGreat job by the brilliant @pilardomingoc.bsky.social and her team!
- A patient with cystic fibrosis overcomes acute rejection of lung transplant through phage therapy www.i2sysbio.es/communicatio... bravo @pilardomingoc.bsky.social 👏
- Reposted by Pilar Domingo-CalapA patient with cystic fibrosis overcomes acute rejection of lung transplant through phage therapy www.i2sysbio.es/communicatio... bravo @pilardomingoc.bsky.social 👏
- Reposted by Pilar Domingo-Calap✍️ Vos deixem per ací l'article sobre els fags que va escriure per a Mètode en el número 112: «Els virus dels bacteris» 🦠
- Reposted by Pilar Domingo-Calap#UV | 🔬Una pacient amb fibrosi quística supera amb teràpia de fags el rebuig agut del seu trasplantament pulmonar ℹ️ Més info i accés a l'article complet:
- Reposted by Pilar Domingo-Calap🔬Los fagos salvan vidas @elpais.com publica la historia de cómo un tratamiento experimental de fagoterapia, desarrollado por @pilardomingoc.bsky.social y su equipo en el #I2SysBio (@uv.es- @csic.es), le salvó la vida a Irene, una paciente con fibrosis quística. elpais.com/ciencia/2025...
- Reposted by Pilar Domingo-Calap🗞️ Aquesta matinada El País ha publicat aquest article sobre com els fags, virus que es poden utilitzar per combatre bacteris resistents que no tenen tractament, han salvat la vida d'una pacient. I d'això a Mètode ja va parlar la viròloga @pilardomingoc.bsky.social
- Reposted by Pilar Domingo-Calap🗞️ Esta madrugada El País ha publicado este artículo sobre como los fagos, virus que combaten bacterias, han salvado la vida de una paciente. Y de esto en Mètode ya habló la viróloga @pilardomingoc.bsky.social
- Reposted by Pilar Domingo-CalapA ver si lo ve @davidbroncano.bsky.social ...
- Reposted by Pilar Domingo-CalapAlgunos en el @i2sysbio.es hacemos "cosas" y luego hay gente como @pilardomingoc.bsky.social que hace esto 👇 Brava! 👩🔬😍🧫♀️🧪 elpais.com/ciencia/2025...
- Reposted by Pilar Domingo-CalapCongratulations to our multidisciplinary team: @i2sysbio.es 🇪🇸: Vicente Arnau @vicentarnau.bsky.social, Alicia Ortiz-Maiques, Juan Valero-Tebar, Lucas Mora-Quilis, Pilar Domingo-Calap @pilardomingoc.bsky.social @atrandi.bsky.social 🇱🇹: Vaida Kurmauskaite, Lorea Campos Dopazo #womeninSTEM #microsky
- Reposted by Pilar Domingo-Calap🚨 Abstract submission is open for Pangenome2025 in Valencia! #microsky #bioinformatics 🧪🦠🧬🖥️ I’m one of the invited speakers. Looking forward to the talks by my @i2sysbio.es colleague Pilar Domingo-Calap @pilardomingoc.bsky.social, and many other great researchers. www.alocongress.com/pangenome2025 🧵
- Reposted by Pilar Domingo-Calap🫁New in #ASMCaseReports 🫁 Marco Pardo-Freire et al. present a case where phage therapy was used to resolve acute rejection in a bilateral double-lung transplanted patient with cystic fibrosis. @csic.es @pilardomingoc.bsky.social @asm.org Explore the case: doi.org/10.1128/asmc...
- Planazo de domingo! Leyendo Los Buenos Virus en la playa!! Gracias JAL @jalguerrero.bsky.social por dar a conocer el lado bueno de los virus, incluyendo nuestras investigaciones en fagos en la lucha contra bacterias resistentes @i2sysbio.es #EnBiVirLab #VLCphagehunters #EVOLVINGTHERAPEUTICS
- Reposted by Pilar Domingo-Calap🧪📽️ La investigadora @pilardomingoc.bsky.social presenta su grupo de investigación Virología Ambiental y Biomédica. Esta entrevista forma parte de una serie de vídeos que ha lanzado el #I2SysBio (@csic.es - @uv.es) sobre los diferentes grupos del centro. #virology www.youtube.com/watch?v=vOgg...
- Reposted by Pilar Domingo-CalapEn tiempos de infecciones con bacterias multiresistentes a antibióticos, esto es un notición buenísimo.
- Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir #VLCphagehunters @i2sysbio.es and #EvolvingTherapeutics in collaboration with Dr. de la Villa #GregorioMarañon @uv.es @csic.es www.sciencedirect.com/science/arti...
- Reposted by Pilar Domingo-CalapMy colleague Pilar Domingo-Calap @pilardomingoc.bsky.social successfully treated a patient with prosthetic joint infection by her phage therapy 👏👏🏆🦠🧪🧫 #microsky #viruses #phages @uv.es @csic.es @ucciuv.bsky.social
- Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir #VLCphagehunters @i2sysbio.es and #EvolvingTherapeutics in collaboration with Dr. de la Villa #GregorioMarañon @uv.es @csic.es www.sciencedirect.com/science/arti...
- Reposted by Pilar Domingo-CalapOur researcher Pilar Domingo-Calap @pilardomingoc.bsky.social successfully treated a patient with prosthetic joint infection by her phage therapy 👏👏🏆🦠🧪🧫 #microsky #viruses #phages @uv.es @csic.es @ucciuv.bsky.social
- Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir #VLCphagehunters @i2sysbio.es and #EvolvingTherapeutics in collaboration with Dr. de la Villa #GregorioMarañon @uv.es @csic.es www.sciencedirect.com/science/arti...
- Phage therapy in a patient with prosthetic join infection in Spain! Another sucessful treatment from the #EnBiVir #VLCphagehunters @i2sysbio.es and #EvolvingTherapeutics in collaboration with Dr. de la Villa #GregorioMarañon @uv.es @csic.es www.sciencedirect.com/science/arti...
- Reposted by Pilar Domingo-CalapNow time for @pilardomingoc.bsky.social presenting #EvolvingTherapeutics By the way, just appointed #AssociateProfessor at the @ccbiologiquesuv.bsky.social @uv.es Congrats Pilar!!! 👏🏻👏🏻👏🏻
- Reposted by Pilar Domingo-CalapInspiradora jornada 'Career Opportunities in Science: Creating a Start-up', organizada por nuestra Comisión Posdoctoral en el #CNB_CSIC, con @pilardomingoc.bsky.social (Evolving Therapeutics) y José M. Ripalda (Future Voltaics) compartiendo sus experiencias emprendiendo en #ciencia.
- Our first collaboration with @josepsardanyes.bsky.social, first of many more! Great job Marcos and Irene.
- Reposted by Pilar Domingo-CalapMarcos Rodríguez, Irene Cantallops, Pilar Domingo-Calap @pilardomingoc.bsky.social & Josep Sardanyés @josepsardanyes.bsky.social from I2SysBio published a paper about quantifying dynamics of #Klebsiella and its #phages, focused on phage-resistant mutants 🦠🧪 #microsky @csic.es @ucciuv.bsky.social
- Reposted by Pilar Domingo-Calap🧪 🦠 #pintofscience #womeninSTEM Tres investigadoras del I2SysBio participarán este año en Pint of Science! Este evento internacional de divulgación científica tendrá lugar del 19 al 21 de mayo de 2025. 🌐 pintofscience.es/events/valen... ¿Dónde y cuándo podrás ver sus charlas?⬇️
- Reposted by Pilar Domingo-Calap🧪Cecilia Picazo @cecipicam.bsky.social hablará sobre las levaduras 🗓️ 20.5., Max Max. 🧪Pilar Domingo-Calap @pilardomingoc.bsky.social hablará sobre los bacteriófagos 🗓️ 21.5., George Best Rock Club. 🧪Maria Dzunkova @dzunkovam.bsky.social hablará sobre la materia oscura microbiana 🗓️ 21.5., Max Max.
- Reposted by Pilar Domingo-CalapOn 20th May, join us at the CNB for Career Opportunities in Science: Creating a Start-up, organized by our Postdoc Commission, with talks by Dr. @pilardomingoc.bsky.social (Evolving Therapeutics) & Dr. José M. Ripalda (Future Voltaics).
- Reposted by Pilar Domingo-Calap🧪 Finally out after peer review, our work showing that "Mobile #Integrons carry Phage Defense Systems" is now published in Science 🎉 Short 🧵 www.science.org/doi/10.1126/...
- Muchas gracias!!! Ojalá que al menos nos permitan su uso compasivo a mayor escala y poder ayudar a más personas!
- El episodio 226 de #NOOSFERA me ha dejado asombrado sobre los usos actuales y potencial futuro de los virus bacteriófagos. Después de escuchar a @pilardomingoc.bsky.social voy a pedir un cambio en el impreso de declaración de la renta
- Reposted by Pilar Domingo-CalapMobile Integrons Encode Phage Defense Systems | bioRxiv biorxiv.org/content/10.1101/202…
- Reposted by Pilar Domingo-CalapMy colleague Pilar Domingo-Calap @pilardomingoc.bsky.social from I2SysBio @i2sysbio.bsky.social got Women TechEU prize for the #phagetherapy implemented by her spin-off company Evolving Therapeutics. Congratulations 👏 #phages #microsky 🧫🦠🧪 #WomeninSTEM 👩🔬
- Antimicrobial resistance is a major threat. At Evolving Therapeutics, we develop phage-based solutions to combat multi-drug resistantat bacteria. Women TechEU is a recognition of our effort and dedication, and a step forward in the implementation of phage therapy in Spain www.uv.es/uvweb/uv-new...
- Reposted by Pilar Domingo-CalapCongratulations to our researcher Pilar Domingo-Calap @pilardomingoc.bsky.social for being awarded by the Women TechEU prize for the #phagetherapy implemented by her spin-off company Evolving Therapeutics 👏 #phages #microsky 🧫🦠🧪 #WomeninSTEM 👩🔬
- Antimicrobial resistance is a major threat. At Evolving Therapeutics, we develop phage-based solutions to combat multi-drug resistantat bacteria. Women TechEU is a recognition of our effort and dedication, and a step forward in the implementation of phage therapy in Spain www.uv.es/uvweb/uv-new...
- Antimicrobial resistance is a major threat. At Evolving Therapeutics, we develop phage-based solutions to combat multi-drug resistantat bacteria. Women TechEU is a recognition of our effort and dedication, and a step forward in the implementation of phage therapy in Spain www.uv.es/uvweb/uv-new...
- Reposted by Pilar Domingo-Calap🚨Job offer at our research institute I2SysBio 🇪🇸: Contract for International Program Management, specialized in ERC @erc.europa.eu programs 🧪 #science #researchgrants #JOBOFFER #i2sysbio @ucciuv.bsky.social @csic.es @uv.es i2sysbio.es/position/4/
- Reposted by Pilar Domingo-Calap@pilardomingoc.bsky.social Acabo de escuchar el episodio de #Noosfera en el que hablas con Ignacio Crespo sobre fagos. Que pasada 😲 open.spotify.com/episode/1mZS...
- Reposted by Pilar Domingo-Calap🦠 Llegamos a la Mesa Redonda del #IIICongresoVirología #MásterVirología @ccbiologiquesuv.bsky.social @uv.es con un lujazo d ponentes #JoseALopezGuerreroJAL @virusemergentes.bsky.social y @pilardomingoc.bsky.social
- Reposted by Pilar Domingo-Calap🦠 Turno para #MargaritadelVal @cbm-csic-uam.bsky.social “¿Estamos más preparados para próximas pandemias? #IIICongresoVirología @ccbiologiquesuv.bsky.social @uv.es
- Reposted by Pilar Domingo-CalapHoy y mañana disfrutaremos del #IIICongresoVirologia #MasterVirologia @ccbiologiquesuv.bsky.social @uv.es organizado por nuestros estudiantes del máster q han conseguido reunir un programa fantástico y q sin duda les ha servido para demostrar su excelencia más allá del aula www.uv.es/uvweb/biolog...
- Reposted by Pilar Domingo-Calap¿Es el intestino nuestro segundo cerebro? Comienza el tour: Sevilla: jueves 20 de febrero (18:00) Madrid: miércoles 5 de marzo (19:00) Palma: jueves 13 de marzo (19:00) Valencia: miércoles 9 de abril (18:30) Zaragoza: martes 6 de mayo (18:00) Reserva: microbioblog.es/es-el-intest...
- Amazing reflection of Marisa Domingo, CEO of #EVOLVINGTHERAPEUTICS, where she talks about the role of women in science. Reading it gives us visibility and brings us closer to a problematic that still requires effort and dedication! #WomeninSTEM www.eldiario.es/comunitat-va...
- Reposted by Pilar Domingo-CalapPilar Domingo-Calap @pilardomingoc.bsky.social from our research institute was invited to give a talk about her #phage therapy for treatment of respiratory infections #superbugs #microsky #virology 🧪🦠🧫🔬
